S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Critical asset just had biggest fall on record (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Critical asset just had biggest fall on record (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Critical asset just had biggest fall on record (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Critical asset just had biggest fall on record (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?

Basilea Pharmaceutica (BPMUF) Short Interest Ratio & Short Volume

$40.75
0.00 (0.00%)
(As of 02/27/2024 ET)

Basilea Pharmaceutica Short Interest Data

Current Short Volume
251,600 shares
Previous Short Volume
276,900 shares
Change Vs. Previous Month
-9.14%
Dollar Volume Sold Short
$10.25 million
Short Interest Ratio / Days to Cover
2,516.0
Last Record Date
February 15, 2024
Outstanding Shares
11,850,000 shares
Percentage of Shares Shorted
2.12%
Today's Trading Volume
0 shares
Average Trading Volume
0 shares
Today's Volume Vs. Average
0%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Basilea Pharmaceutica ?

Sign up to receive the latest short interest report for Basilea Pharmaceutica and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BPMUF Short Interest Over Time

BPMUF Days to Cover Over Time

BPMUF Percentage of Float Shorted Over Time


Basilea Pharmaceutica Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/2024251,600 shares $10.25 million -9.1%N/A2516 $40.75
1/15/2024268,800 shares $11.02 million +3.0%N/A0 $41.00
12/31/2023260,900 shares $10.70 million +1.5%N/A0 $41.00
12/15/2023257,100 shares $10.54 million +2.0%N/A0 $41.00
11/30/2023252,100 shares $10.34 million -1.9%N/A0 $41.00
11/15/2023256,900 shares $10.53 million -0.7%N/A0 $41.00
10/31/2023258,800 shares $10.61 million -9.0%N/A2588 $41.00
10/15/2023284,400 shares $14.22 million -1.4%N/A0 $50.00
9/30/2023288,300 shares $14.42 million +7.5%N/A0 $50.00
9/15/2023268,300 shares $13.42 million -2.9%N/A0 $50.00
8/31/2023276,400 shares $13.82 million -9.2%N/A0 $50.00
8/15/2023304,300 shares $15.22 million +2.6%N/A0 $50.00
7/31/2023296,600 shares $14.83 million -12.1%N/A0 $50.00
7/15/2023337,300 shares $16.87 million -2.9%N/A0 $50.00
6/30/2023347,200 shares $17.36 million +4.0%N/A0 $50.00
6/15/2023333,900 shares $16.70 million -1.6%N/A3339 $50.00
5/31/2023339,200 shares $16.96 million +0.6%N/A3392 $50.00
5/15/2023337,300 shares $17.54 million -14.7%N/A3373 $52.00
4/30/2023395,600 shares $20.57 million +0.4%N/A0 $52.00
4/15/2023394,000 shares $20.49 million +0.5%N/A0 $52.00
3/31/2023392,200 shares $20.39 million +5.5%N/A0 $52.00
3/15/2023371,700 shares $19.33 million +0.5%N/A0 $52.00
2/28/2023369,700 shares $19.22 million -4.5%N/A0 $52.00
2/15/2023386,900 shares $20.12 million +3.6%N/A0 $52.00
1/31/2023373,400 shares $19.42 million +1.3%N/A0 $52.00
1/15/2023368,800 shares $19.18 million -0.1%N/A0 $52.00
12/30/2022369,000 shares $19.19 million +0.2%N/A0 $52.00
12/15/2022368,300 shares $19.15 million -0.9%N/A0 $52.00
11/30/2022371,800 shares $19.33 million -2.2%N/A3718 $52.00
11/15/2022380,200 shares $17.49 million -0.1%N/A3802 $46.00
10/31/2022380,600 shares $15.60 million -3.7%N/A0 $41.00
10/15/2022395,100 shares $16.20 million -2.7%N/A0 $41.00
9/30/2022406,100 shares $16.65 million +0.5%N/A0 $41.00
9/15/2022404,200 shares $16.57 million +6.2%N/A4042 $41.00
8/31/2022380,700 shares $15.61 million -5.5%N/A0 $41.00
8/15/2022402,900 shares $16.52 million -21.8%N/A0 $41.00
7/31/2022515,400 shares $21.13 million -19.0%N/A0 $41.00
7/15/2022635,900 shares $26.07 million -1.9%N/A0 $41.00
6/30/2022648,000 shares $26.57 million -1.3%N/A0 $41.00
6/15/2022656,300 shares $26.91 million -2.0%N/A0 $41.00













BPMUF Short Interest - Frequently Asked Questions

What is Basilea Pharmaceutica's current short interest?

Short interest is the volume of Basilea Pharmaceutica shares that have been sold short but have not yet been closed out or covered. As of February 15th, traders have sold 251,600 shares of BPMUF short. Learn More on Basilea Pharmaceutica's current short interest.

What is a good short interest ratio for Basilea Pharmaceutica?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BPMUF shares currently have a short interest ratio of 2,516.0. Learn More on Basilea Pharmaceutica's short interest ratio.

Is Basilea Pharmaceutica's short interest increasing or decreasing?

Basilea Pharmaceutica saw a decline in short interest during the month of February. As of February 15th, there was short interest totaling 251,600 shares, a decline of 9.1% from the previous total of 276,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Basilea Pharmaceutica's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Basilea Pharmaceutica: Arbutus Biopharma Co. (2.20%), Revance Therapeutics, Inc. (14.05%), Amarin Co. plc (4.15%), KalVista Pharmaceuticals, Inc. (12.35%), Nurix Therapeutics, Inc. (14.87%), Phibro Animal Health Co. (4.53%), Avid Bioservices, Inc. (8.93%), Terns Pharmaceuticals, Inc. (11.50%), Longboard Pharmaceuticals, Inc. (9.83%), Janux Therapeutics, Inc. (8.59%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Basilea Pharmaceutica stock?

Short selling BPMUF is an investing strategy that aims to generate trading profit from Basilea Pharmaceutica as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Basilea Pharmaceutica?

A short squeeze for Basilea Pharmaceutica occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BPMUF, which in turn drives the price of the stock up even further.

How often is Basilea Pharmaceutica's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPMUF, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (OTCMKTS:BPMUF) was last updated on 2/29/2024 by MarketBeat.com Staff